Studies link Dupixent to cutaneous T-cell lymphoma (CTCL), a rare cancer that affects the skin. Learn about lawsuits and see if you qualify to file a case.
In 2015, DrugWatch reported how oversight and shortcuts at the FDA put women at risk. After 10 years, we follow up on what’s improved and where medical device and drug gaps still leave women vulnerable.